Posts

Showing posts from April, 2023

Tips for Marketing Weight Loss Services to Prescribers

Tips for Marketing Weight Loss Services to Prescribers  by Dr. Lisa Faast Unless you have been hiding under a rock, you have probably noticed that weight loss drugs are a hot topic. Your compounding pharmacy can utilize this by marketing your weight loss compounds and services to local prescribers.  Thanks to the popularity of branded diabetic and weight loss drugs, it seems the whole country is talking about weight loss solutions. This chatter creates an excellent opportunity to provide needed products and services to your community. While some weight-loss options don't require a prescription or a medical practitioner, many of the most sought-after solutions do.  Here are some proven tactics you can use to market your weight loss solutions to prescribers in your area.  Coupons, Specials, & Deals Targeted Marketing Materials Prescribing Cheat Sheets Provide Extensive Patient Support Cater to Prescriber Preferences Let's break these down in detail so you can become highly ef

Managing Drug Shortages: Compounding Pediatric Pharmaceutical Suspensions

  Managing Drug Shortages: Compounding Pediatric Pharmaceutical Suspensions By Anna Vratsista Drug shortages have become a serious problem affecting patients and healthcare providers worldwide. According to the American Society of Health-System Pharmacists (ASHP), drug shortages have increased rapidly in the past decade, with over 350 drugs currently in short supply in the U.S. alone. 1 The etiology of the problem is complicated but there are a few main factors that contribute to drug shortages, including problems at manufacturing process, quality and regulatory problems, natural disasters, global pandemic, and economic factors. Many of the current drug shortages, are the result of the global pandemic COVID-19, where increased demand, supply chain disruptions and trade restrictions have caused shortages of many drugs. 2 Drug shortages can have serious consequences for patients, healthcare providers and drug manufacturers. Patients may face delayed or interrupted treatments, in